PPARGC1A and steatosis: The 209% rise in SOD activity (Table 5) is consistent with activation of PGC-1α–mediated mitochondrial biogenesis, a mechanism shown to reverse steatosis in animal models and primary hepatocytes; overexpression of PGC-1α promotes mitochondrial proliferation and fatty acid oxidation, thereby reducing hepatic lipid accumulation [51].